182 related articles for article (PubMed ID: 20610622)
1. The mitogen-activated protein kinase kinase 4 has a pro-oncogenic role in skin cancer.
Finegan KG; Tournier C
Cancer Res; 2010 Jul; 70(14):5797-806. PubMed ID: 20610622
[TBL] [Abstract][Full Text] [Related]
2. Functional roles of Akt signaling in mouse skin tumorigenesis.
Segrelles C; Ruiz S; Perez P; Murga C; Santos M; Budunova IV; Martínez J; Larcher F; Slaga TJ; Gutkind JS; Jorcano JL; Paramio JM
Oncogene; 2002 Jan; 21(1):53-64. PubMed ID: 11791176
[TBL] [Abstract][Full Text] [Related]
3. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
4. Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia.
Scholl FA; Dumesic PA; Barragan DI; Harada K; Charron J; Khavari PA
Cancer Res; 2009 May; 69(9):3772-8. PubMed ID: 19383924
[TBL] [Abstract][Full Text] [Related]
5. Role of mitogen-activated protein kinase kinase 4 in cancer.
Whitmarsh AJ; Davis RJ
Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
[TBL] [Abstract][Full Text] [Related]
6. Reversible regulation of the transformed phenotype of ornithine decarboxylase- and ras-overexpressing cells by dominant-negative mutants of c-Jun.
Kielosto M; Nummela P; Katainen R; Leaner V; Birrer MJ; Hölttä E
Cancer Res; 2004 Jun; 64(11):3772-9. PubMed ID: 15172983
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth.
Liu W; Zi M; Jin J; Prehar S; Oceandy D; Kimura TE; Lei M; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2009 Apr; 104(7):905-14. PubMed ID: 19265040
[TBL] [Abstract][Full Text] [Related]
8. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.
Lozano J; Xing R; Cai Z; Jensen HL; Trempus C; Mark W; Cannon R; Kolesnick R
Cancer Res; 2003 Jul; 63(14):4232-8. PubMed ID: 12874031
[TBL] [Abstract][Full Text] [Related]
10. Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.
To MD; Rosario RD; Westcott PM; Banta KL; Balmain A
Oncogene; 2013 Aug; 32(34):4028-33. PubMed ID: 22945650
[TBL] [Abstract][Full Text] [Related]
11. Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death.
Wang X; Nadarajah B; Robinson AC; McColl BW; Jin JW; Dajas-Bailador F; Boot-Handford RP; Tournier C
Mol Cell Biol; 2007 Nov; 27(22):7935-46. PubMed ID: 17875933
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D
Cancer Res; 2001 Aug; 61(16):6082-8. PubMed ID: 11507057
[TBL] [Abstract][Full Text] [Related]
13. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
14. Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.
Wu L; Jiang H; Chawsheen HA; Mishra M; Young MR; Gerard M; Toledano MB; Colburn NH; Wei Q
Carcinogenesis; 2014 May; 35(5):1177-84. PubMed ID: 24503444
[TBL] [Abstract][Full Text] [Related]
15. C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event.
Messenger ZJ; Hall JR; Jima DD; House JS; Tam HW; Tokarz DA; Smart RC
Cell Death Dis; 2018 Oct; 9(11):1054. PubMed ID: 30323292
[TBL] [Abstract][Full Text] [Related]
16. Crucial role of phospholipase Cepsilon in chemical carcinogen-induced skin tumor development.
Bai Y; Edamatsu H; Maeda S; Saito H; Suzuki N; Satoh T; Kataoka T
Cancer Res; 2004 Dec; 64(24):8808-10. PubMed ID: 15604236
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
[TBL] [Abstract][Full Text] [Related]
18. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas.
Park E; Zhu F; Liu B; Xia X; Shen J; Bustos T; Fischer SM; Hu Y
Cancer Res; 2007 Oct; 67(19):9158-68. PubMed ID: 17909021
[TBL] [Abstract][Full Text] [Related]
19. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of oncogenic K-ras signaling by aerosolized gene delivery in a mouse model of human lung cancer.
Lee HY; Suh YA; Lee JI; Hassan KA; Mao L; Force T; Gilbert BE; Jacks T; Kurie JM
Clin Cancer Res; 2002 Sep; 8(9):2970-5. PubMed ID: 12231543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
